Treatments & Services
Our Fertility and Reproductive Health experts offer a comprehensive array of treatments and services, including:
Fertility Preservation for Women
Our Elective Fertility Preservation program provides the opportunity to women who wish to preserve their ability to have children in the future, as they age. The elective oocyte/embryo cryopreservation program was started in 2002. We offer the opportunity to freeze oocytes (eggs) or embryos. The process and treatment is similar to the IVF process with the exception of the transfer of embryos.
A fertility treatment in which a catheter is used to place sperm directly into a woman's uterus to increase the number of sperm that reach the fallopian tubes and subsequently increase the chance of fertilization.
In Vitro Fertilization (IVF)
One of the most common and effective types of assisted reproductive technology to help women become pregnant; the procedure involves fertilizing an egg outside the body, in a laboratory dish, and then implanting it in a woman's uterus.
Our physicians work with you to individualize the predicted chances of IVF success based on your unique situation.
The use of medications to stimulate the follicles in the ovaries, resulting in the release of multiple eggs in one cycle to increase chances of fertilization.
Fertility Services for Men
We provide comprehensive diagnostic and treatment options through our male reproductive urologist, as well as laboratory services for men including, semen analysis, sperm preparation for intrauterine insemination, and full service andrology testing.
Fertility Preservation for Cancer Patients
The oocyte cryopreservation program for cancer patients was the first of its kind, and this service has been offered under an IRB protocol since 1999. We offer the opportunity to freeze oocytes (eggs), embryos, and ovarian tissue. Ovarian tissue freezing is typically done in patients who are having abdominal surgery.
We also offer cryopreservation of sperm for men facing cancer treatment and surgery.
Patients 15-29 years of age who are receiving cancer treatment have fertility preservation options as well. The Stanford Adolescent and Young Adult Cancer Program provides counseling and assistance with family planning, fertility preservation and sexual health.
We partner with Fertile Hope to offer cancer patients help through the Sharing Hope Program.
Preimplantation Genetic Diagnosis (PGD)
When a parent or parents carry a mutation that puts them at risk for having a child with a hereditary disorder, preimplantation testing of embryos can diagnose an embryo as affected or unaffected and embryos which do not carry the affected gene can be selected for transfer. This process is called PGD. It can significantly reduce the chances of having an affected child. It is typically done on patients who have no difficulty conceiving. Many couples know that they are at risk due to a family member with the disease, but some patients may be silent carriers. Preconception carrier screening can help identify patients and couples at risk for having a baby with a common genetic syndrome.
Preimplantation Genetic Screening (PGS or CCS)
Preimplantation genetic screening is different from PGD because it is done on patients who do not carry a known disease-causing mutation, but wish to reduce their chances of chromosomal imbalance which could lead to miscarriage or a baby with an extra or missing chromosome, such as Down’s syndrome. As women age, their eggs are at higher risk of carrying a missing or extra chromosome. Preimplantation genetic screening of embryos can include all 24 chromosomes and is, therefore, sometimes referred to as comprehensive chromosome screening (CCS). PGS can be performed in conjunction with a standard IVF cycle in any couple, but is typically considered in patients where the female partner is over 35 years of age. An additional benefit of PGS is that it improves our ability to choose the healthier embryos in a cohort, achieving a high success rate with a single embryo transfer and reducing the risks of twin pregnancies.
Surgical correction of disorders of the reproductive system which may be causing fertility issues; many abnormalities can be treated with minimally-invasive surgery.
Reproductive Endocrinology and Infertility (REI) Laboratory
Our REI lab provides comprehensive services for women and men. It is accredited by the State of California and holds a tissue bank license. Our experienced laboratory staff of California licensed technologists and phlebotomists are all highly specialized in the field of reproductive technology. The laboratory staff interacts with the clinical staff to achieve the very best in patient care.
Our endocrine laboratory uses the state-of-the-art AIA 2000 to offer a full panel of reproductive hormone analysis. Test results are usually returned the same day, when samples are received by 10 AM.
Our andrology laboratory uses a CASA system (Computer Assisted Semen Analyzer), CEROS Sperm Analyzer, for semen analysis and sperm washes. A strict Kruger morphology may also be requested by your physician. Sperm cryopreservation is offered, but long-term storage arrangements must be made with a cryobank.
We provide genetic counseling for couples seeking additional information about preconception and preimplantation genetic testing options. Our genetic counselor helps patients understand and adapt to the medical, psychological and familial impact of genetic disease; and interprets family and medical histories to assess the chance of disease occurring or recurring—the goal being to promote informed choices. Learn more about reasons to meet with a fertility genetic counselor.
Third Party Reproduction (IVF)
Third Party Reproduction involves the use of another person either known or anonymous to assist a person or couple in achieving pregnancy.
Stanford Medicine Fertility and Reproductive Health is one of the largest programs in the Bay Area. We offer egg donation and In Vitro fertilization (IVF) with a gestational carrier as ways to achieve pregnancy. Our team of experts will work with donor agencies to help you identify the anonymous donor who will best suit your needs and/or with a donor who is known to you prior to starting your treatment (e.g. sister, cousin or friend). The same is true of our Gestational Carrier program.